ALCON's VEXOL OPHTHALMIC CORTICOSTEROID APPROVED DEC. 30 FOR TREATING POSTOP INFLAMMATION AND ANTERIOR UVEITIS; LAST 1994 NME RECEIVES PRIORITY REVIEW